NBW Capital LLC Raises Holdings in STERIS plc $STE

NBW Capital LLC lifted its stake in STERIS plc (NYSE:STE) by 7.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 23,254 shares of the medical equipment provider’s stock after purchasing an additional 1,687 shares during the quarter. NBW Capital LLC’s holdings in STERIS were worth $5,586,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of STERIS by 1.7% during the second quarter. Vanguard Group Inc. now owns 12,163,128 shares of the medical equipment provider’s stock worth $2,921,827,000 after buying an additional 205,276 shares during the period. Generation Investment Management LLP raised its stake in STERIS by 5.4% in the 1st quarter. Generation Investment Management LLP now owns 3,354,545 shares of the medical equipment provider’s stock worth $760,308,000 after acquiring an additional 170,392 shares during the last quarter. Geode Capital Management LLC raised its stake in STERIS by 1.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,479,108 shares of the medical equipment provider’s stock worth $592,980,000 after acquiring an additional 46,859 shares during the last quarter. Orbis Allan Gray Ltd acquired a new stake in STERIS during the 1st quarter worth about $349,950,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in STERIS by 55.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,520,479 shares of the medical equipment provider’s stock valued at $344,617,000 after purchasing an additional 540,999 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Performance

STE opened at $262.99 on Tuesday. The firm has a fifty day moving average price of $248.91 and a 200 day moving average price of $243.10. STERIS plc has a 1 year low of $200.98 and a 1 year high of $268.60. The stock has a market cap of $25.81 billion, a P/E ratio of 40.27 and a beta of 1.02. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. The company had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. STERIS had a net margin of 11.61% and a return on equity of 14.17%. During the same quarter in the previous year, the company earned $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Equities research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Tuesday, November 18th will be issued a $0.63 dividend. The ex-dividend date of this dividend is Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s dividend payout ratio is presently 36.21%.

Analyst Ratings Changes

Several brokerages have recently issued reports on STE. Morgan Stanley raised their price objective on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research note on Friday, August 8th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Finally, Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $273.50.

Insiders Place Their Bets

In other STERIS news, CEO Daniel A. Carestio sold 159 shares of the stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $241.82, for a total transaction of $38,449.38. Following the transaction, the chief executive officer owned 51,096 shares in the company, valued at approximately $12,356,034.72. This represents a 0.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Julia Madsen sold 5,008 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the completion of the sale, the vice president owned 10,710 shares of the company’s stock, valued at $2,806,020. This trade represents a 31.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 25,203 shares of company stock worth $6,624,667. Company insiders own 1.07% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.